The Valley Desk

NCT01952574 · Interventional trial

Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention

Overall registry status Completed

Phase 2

Conditions Migraine

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov